Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McCarty

Showing results (141-150 of 405) with videos related to

Pageof 41
Sort By:
JAMA|April 19, 2000
Dietary fiber and weight gainM F McCarty
Medical Hypotheses|June 27, 2001
Current prospects for controlling cancer growth with non-cytotoxic agents--nutrients, phytochemicals, herbal extracts, and available drugsM F McCarty
Medical Hypotheses|July 20, 2001
Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesityM F McCarty
Medical Hypotheses|July 20, 2001
Concurrent administration of sustained-release bezafibrate may counteract the increased thrombotic risk associated with oral estrogen therapyM F McCarty
Medical Hypotheses|January 3, 2001
Inhibition of CYP2E1 with natural agents may be a feasible strategy for minimizing the hepatotoxicity of ethanolM F McCarty
Medical Hypotheses|April 15, 2004
Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytesMark F McCarty
Medical Hypotheses|July 9, 2004
AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthaseMark F McCarty
Medical Hypotheses|December 21, 2004
De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndromeMark F McCarty
Medical Hypotheses|March 4, 2006
Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disordersMark F McCarty
Medical Hypotheses|October 1, 1994
Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression--an adjuvant role for chromium picolinate?M F McCarty
Pageof 41

Showing results (141-150 of 405) with videos related to

Sort By:
Pageof 41
JAMA|April 19, 2000
Dietary fiber and weight gainM F McCarty
Medical Hypotheses|June 27, 2001
Current prospects for controlling cancer growth with non-cytotoxic agents--nutrients, phytochemicals, herbal extracts, and available drugsM F McCarty
Medical Hypotheses|July 20, 2001
Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesityM F McCarty
Medical Hypotheses|July 20, 2001
Concurrent administration of sustained-release bezafibrate may counteract the increased thrombotic risk associated with oral estrogen therapyM F McCarty
Medical Hypotheses|January 3, 2001
Inhibition of CYP2E1 with natural agents may be a feasible strategy for minimizing the hepatotoxicity of ethanolM F McCarty
Medical Hypotheses|April 15, 2004
Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytesMark F McCarty
Medical Hypotheses|July 9, 2004
AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthaseMark F McCarty
Medical Hypotheses|December 21, 2004
De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndromeMark F McCarty
Medical Hypotheses|March 4, 2006
Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disordersMark F McCarty
Medical Hypotheses|October 1, 1994
Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression--an adjuvant role for chromium picolinate?M F McCarty
Pageof 41